ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

September 17, 1976

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

NCI-Approved Clinical Trials

August 31, 2001